NAT10 expression was higher in cancer groups compared with the respective normal groups, including bladder, breast, colorectal, esophageal, gastric, liver, lung, kidney, and prostate cancers, as well as leukemia and myeloma. The gene discussed is NAT10; the disease is plasma cell myeloma.